Generic drug maker Mylan may buy Swedish rival Meda: FT
(Reuters) - Generic drug maker Mylan Inc is looking to buy Swedish rival Meda AB in a deal that would create a $23 billion pharmaceutical company, the...
Source: http://feeds.reuters.com/~r/reuters/healthNews/~3/iOxc5r3MG6s/story01.htm
No comments:
Post a Comment